{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T13:11:14Z","timestamp":1699794674120},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T00:00:00Z","timestamp":1153180800000},"content-version":"vor","delay-in-days":12482,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[1972,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rifampicin has a marked inhibitory effect on Rauscher\u2010virus\u2010induced leukaemia. Up to 90% inhibition of splenomegaly can be achieved when the drug is administered immediately after infection. It is suggested that these results may have implications for a rational leukaemia therapy.<\/jats:p>","DOI":"10.1002\/ijc.2910090316","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T14:33:30Z","timestamp":1171895610000},"page":"595-598","source":"Crossref","is-referenced-by-count":9,"title":["Inhibitory effect of rifampicin on rauscher\u2010virusinduced murine leukaemia"],"prefix":"10.1002","volume":"9","author":[{"given":"A. L. J.","family":"Gielkens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. T H. M.","family":"Burghouts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bloemendal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,18]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(71)90547-X"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/newbio232214a0"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/230249a0"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1190749"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.7.1441"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/newbio232212a0"},{"key":"e_1_2_1_8_1","first-page":"10","article-title":"An in vivo assay for antiviral agents effective against the murine leukemogenic Rauscher virus","volume":"4","author":"Chirigos M. A.","year":"1963","journal-title":"Proc. Amer. Ass. Cancer Res."},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/2241277a0"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/228927a0"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/newbio229111a0","article-title":"Inhibitors of the RNA and DNA dependent polymerase activities of RNA tumour viruses","volume":"229","author":"Gurgo C.","year":"1971","journal-title":"Nature New Biol."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.8.1844"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/jvi.7.2.221-226.1971","article-title":"Deoxyri\u2010bonucleic acid polymerase activity associated with a plasma particulate fraction from patients with chronic lymphocytic leukemia","volume":"7","author":"Kiessling A. A.","year":"1971","journal-title":"J. Virol."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.24.64"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/newbio232058a0"},{"key":"e_1_2_1_16_1","first-page":"269","article-title":"Growth curve of a murine leukemia virus in mice","volume":"32","author":"Rauscher F. J.","year":"1964","journal-title":"J. nat. Cancer Inst."},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/jvi.8.1.62-65.1971","article-title":"Mechanism of oncogenic transformation by Rous sarcoma virus. II. Effect of rifampicin on Rous sarcoma virus infection","volume":"8","author":"Richert N. J.","year":"1971","journal-title":"J. Virol."},{"key":"e_1_2_1_18_1","first-page":"785","article-title":"Inhibition of growth uninfected and Rous sarcoma virus\u2010infected chick embryo fibroblasts by rifampicin","volume":"46","author":"Robinson H. L.","year":"1971","journal-title":"J. nat. Cancer Inst."},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.1.182"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/231097a0"},{"key":"e_1_2_1_21_1","first-page":"557","article-title":"Nature of the provirus of Rous sarcoma","volume":"17","author":"Temin H. M.","year":"1964","journal-title":"Nat. Cancer Inst. Monogr."},{"key":"e_1_2_1_22_1","first-page":"2032","article-title":"Effect on rifampicin and a derivative on cells transformed by Rous Sarcoma Virus","volume":"31","author":"Vaheri A.","year":"1971","journal-title":"Cancer Res."}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.2910090316","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.2910090316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T03:34:40Z","timestamp":1699760080000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.2910090316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1972,5,15]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1972,5,15]]}},"alternative-id":["10.1002\/ijc.2910090316"],"URL":"https:\/\/doi.org\/10.1002\/ijc.2910090316","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[1972,5,15]]}}}